Revvity Inc (NYSE:RVTY) is a company that has been making waves in the financial world. On February 3, 2026, Evercore ISI set a price target of $118 for RVTY, suggesting a potential price increase of about 10.19% from its current price of $107.09. This optimistic outlook is supported by the company's strong financial performance in 2025.

Revvity Inc reported impressive financial results for 2025, surpassing its adjusted earnings per share (EPS) guidance by achieving $5.06. This performance exceeded initial expectations, showcasing the company's ability to navigate challenges effectively. The company also achieved a 3% organic growth for the year, aligning with its original guidance range.

In the fourth quarter, Revvity's diagnostics segment experienced a notable 7% organic growth, driven by a stronger-than-expected performance in immunodiagnostics. This highlights the company's resilience and agility in delivering strong outcomes for its stakeholders. Such growth is a positive indicator for investors considering the stock's potential.

Revvity Inc's confidence in its future potential is evident in its strategic actions. The company repurchased over $800 million worth of shares in 2025, reducing its share count by 8.5 million shares. This move reflects a commitment to its growth initiatives despite facing significant headwinds.

Currently, RVTY's stock price is $107.09, reflecting a decrease of 1.57% with a drop of $1.71 today. The stock's trading range today was between $101.70 and $107.14. Over the past year, RVTY has seen a high of $124.82 and a low of $81.36, with a market capitalization of approximately $12.43 billion. Today's trading volume is 2,888,170 shares.